Psychedelics
Nova Mentis looks at potential psilocybin treatment for obesity and diabetes
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.
Awakn Life Sciences starts study on ketamine treatment for gambling addiction
Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.
Study examines challenges in integrating psilocybin therapy with palliative care
Coryn Mayer says the healthcare system needs to improve if psilocybin therapy is to become a mainstream tool.
Vancouver’s Havn Life announces first psilocybin mushroom harvest in Jamaica
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
Numinus subsidiary files U.S. patent application for rapid production of psychedelic treatments
The Vancouver-based company has a licence from Health Canada to test, sell, and distribute psychedelic substances.
Psychedelics researcher explains why a bad trip is a good one after all
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.